| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/10/2003 | CN1441680A Cyclodextrin containing glycopeptide antibiotic pharmaceutical compositions |
| 09/10/2003 | CN1441679A Compositions containing therapentically active components having enhanced solubility |
| 09/10/2003 | CN1441674A Diphosphonate solutions |
| 09/10/2003 | CN1441672A Methods for treatment of inflammatory diseases |
| 09/10/2003 | CN1441670A Highly efficient delivery of large therapeutic mass aerosol |
| 09/10/2003 | CN1441669A Method for formulating healthcare products with enhanced stability |
| 09/10/2003 | CN1441668A Compositions and methods to improve oral absorption of antimicrobial agents |
| 09/10/2003 | CN1441667A Pharmaceutical compositions |
| 09/10/2003 | CN1441666A Macromolecular drug complexes and compositions containing same |
| 09/10/2003 | CN1440809A New use of neutral proteinase in treating burns |
| 09/10/2003 | CN1440801A Dizziness treating Chinese medicine |
| 09/10/2003 | CN1440800A Heart failure resisting Chinese medicine |
| 09/10/2003 | CN1440791A Freeze dried cyclovirobuxine injection powder for treating cardiac and cerebral vasular diseases |
| 09/10/2003 | CN1440788A Bone injury treating Chinese medicine capsule |
| 09/10/2003 | CN1440782A Prepn process and recipe of composite nano emulsion containing coix seed oil and java brucea fruit |
| 09/10/2003 | CN1440773A Prepn process of Qingkailing injection and injection powder and its quality control method |
| 09/10/2003 | CN1440770A Sheep fetus peptide capsule and its prepn process |
| 09/10/2003 | CN1440760A Dilingquan powder producing process |
| 09/10/2003 | CN1440757A Bioactive Chinese woodfrog oil lecithin powder and its prepn |
| 09/10/2003 | CN1440756A Medicine for treating high fever and diseases caused by high fever and its prepn process |
| 09/10/2003 | CN1440753A Children's brain-nourishing chewing gum |
| 09/10/2003 | CN1440752A Recipe and prepn process of cyclovirobuxine dripping pills |
| 09/10/2003 | CN1440750A Delayed releasing kurarinol prepn |
| 09/10/2003 | CN1440749A Edaravone injection for treating acute cerebral thrombus and its prepn |
| 09/10/2003 | CN1440745A Fluoxetine medicinal preparation |
| 09/10/2003 | CN1440744A Coated nano melatonin composite health tonic |
| 09/10/2003 | CN1440743A Release degree regulator |
| 09/10/2003 | CN1120745C Microcapsule containingt core material and its producing method |
| 09/10/2003 | CN1120724C Stable liquid composition of gamma interferon |
| 09/10/2003 | CN1120719C Aloes lozenge and preparing method thereof |
| 09/10/2003 | CN1120717C Plaster |
| 09/10/2003 | CN1120710C Homorrholdal suppository of draconic sanguis and its producing method |
| 09/09/2003 | US6617486 First aid adhesive plaster |
| 09/09/2003 | US6617356 Comprising a stable suspension of silicon dioxide in a number selected from the group consisting of food grade vegetable oils and mineral oils, and the carrier being in the form of pourable gel |
| 09/09/2003 | US6617353 Prostaglandin derivtives substituted with hydroxypropynyl and carboxyalkylthioalkyl groups, dispersed in a water-soluble polymer; used to treat sleep disorders |
| 09/09/2003 | US6617338 Condensation of omeprazole, lansoprazole or pantoprazole with an addition copolymer having acrylonitrile, acrylic ester or aromatic olefin monomers, to form the polymer conjugate; improved bioavailability |
| 09/09/2003 | US6617328 Sustained release ranolazine formulations |
| 09/09/2003 | US6617321 2-methyl-thieno-benzodiazepine formulation |
| 09/09/2003 | US6617314 Injectable formulations of avermectins and milbemycins |
| 09/09/2003 | US6617307 Useful for treatment of fractures, as a filler in deficient sites of bone, for inhibition of decrease in bone substance related to osteoporosis and periodontic diseases |
| 09/09/2003 | US6617151 Method of closing a cell containment device with a wet seal |
| 09/09/2003 | US6616949 Aqueous solution of biologically active substance is mixed with polyethylene glycol solution;washing concentrated and/or solidified biologically active substance; mixing with solution of biodegradable polymer to emulsify; solidification, drying |
| 09/09/2003 | US6616948 Generating prferential macromolecule carbohydrate; obtain solid carbohydrate, wash, hydrolyze, recover preferential carbohydrate |
| 09/09/2003 | US6616947 Encapsulation system with organic core and mineral cortex based on aluminium hydroxycarbonate and preparation method |
| 09/09/2003 | US6616946 Triblock copolymer hollow particles for agent delivery by permeability change |
| 09/09/2003 | US6616945 Method for making a pharmaceutical formulation |
| 09/09/2003 | US6616944 Self-assembling colloidal carriers for protein delivery |
| 09/09/2003 | US6616943 Composition comprising Wenguanguo extracts and methods for preparing same |
| 09/09/2003 | US6616941 Polymeric composition for solubilizing poorly water soluble drugs and process for the preparation thereof |
| 09/09/2003 | US6616938 Method of making chewing gum containing colloidal bismuth subcitrate |
| 09/09/2003 | US6616933 Excitatory amino acid inhibitors for treating sensitive skins |
| 09/09/2003 | US6616932 Liquid pharmaceutical for oral delivery |
| 09/09/2003 | US6616931 Containing sugar; phosphate; carboxylate; recombinant human serum albumin or a nonionic surfactant |
| 09/09/2003 | US6616914 Method for pulmonary and oral delivery of pharmaceuticals |
| 09/09/2003 | US6616913 Composition and method for treatment of otitis media |
| 09/09/2003 | US6616869 Process for preparing microparticles through phase inversion phenomena |
| 09/09/2003 | US6616652 Osmotic pump delivery system with pre-hydrated membrane(s) and/or primable catheter |
| 09/09/2003 | CA2360287C Crystalline base of citalopram |
| 09/09/2003 | CA2304096C Sustained-release liposomal anesthetic compositions |
| 09/09/2003 | CA2239498C Bioartificial devices and cellular matrices therefor |
| 09/09/2003 | CA2227740C Gastrointestinal drug composition |
| 09/09/2003 | CA2175472C Propylene glycol stearate vesicles |
| 09/09/2003 | CA2057291C A stable pharmaceutical composition of human calcitonin |
| 09/04/2003 | WO2003072741A2 Therapeutic regulation of deoxyribonuclease-1-like-3 activity |
| 09/04/2003 | WO2003072637A1 Carbohydrate-modified polymers, compositions and uses related thereto |
| 09/04/2003 | WO2003072631A1 Biodegradable polymeric material for biomedical applications |
| 09/04/2003 | WO2003072195A2 Method for administering glp-1 molecules |
| 09/04/2003 | WO2003072143A1 Compositions for delivery of therapeutics and other materials, and methods of making and using the same |
| 09/04/2003 | WO2003072141A1 Ophthalmic antibiotic drug formulations containing a cyclodextrin compound and cetyl pyridinium chloride |
| 09/04/2003 | WO2003072140A1 Compression-molded preparions with quick-disintegration properties |
| 09/04/2003 | WO2003072139A1 Pharmaceutical formulation of iressa comprising a water-soluble cellulose derivative |
| 09/04/2003 | WO2003072132A1 Adjuvant system for the production of antibodies, vaccine and use |
| 09/04/2003 | WO2003072130A1 Oxygen carrier system, artificial oxygen carrier and reducing agent |
| 09/04/2003 | WO2003072127A1 Method for drying water-borne materials |
| 09/04/2003 | WO2003072118A1 Micro/nanoparticle obtained from lipid-containing marine organisms for use in pharmaceutics and cosmetics |
| 09/04/2003 | WO2003072115A1 Ceramic composite materials |
| 09/04/2003 | WO2003072113A1 Long acting parasiticidal composition containing a salicylanilide compound, a polymeric species and at least one other anti-parasitic compound |
| 09/04/2003 | WO2003072112A1 'long'-'acting' injectable parasiticidal composition |
| 09/04/2003 | WO2003072108A1 Novel crystalline forms of the anti-cancer compound zd1839 |
| 09/04/2003 | WO2003072095A1 Sofalcone-containing compositions |
| 09/04/2003 | WO2003072094A1 Ambroxol for treating painful conditions in the mouth and pharyngeal cavity |
| 09/04/2003 | WO2003072091A1 Therapeutic methods for acute myeloid leukemia |
| 09/04/2003 | WO2003072089A1 Controlled release dosage forms |
| 09/04/2003 | WO2003072088A1 Capsule for the time-delayed dispensing of nutrients and/or active substances |
| 09/04/2003 | WO2003072087A1 Pharmaceutical dosage form and method for the production thereof |
| 09/04/2003 | WO2003072086A1 Pharmaceutical dosage forms comprising tablet core having a tensile strength below 38 n/sqcm and a coating to protect the soft core |
| 09/04/2003 | WO2003072085A1 Solid preparations with improved absorbability of hardly water-soluble drug |
| 09/04/2003 | WO2003072084A1 Fast disintegrating tablets |
| 09/04/2003 | WO2003072083A2 Melt extrusion consisting of salts of active ingredients |
| 09/04/2003 | WO2003072082A1 Pharmaceutical formulations of antineoplastic agents, in particular temozolomide, processes of making and using the same |
| 09/04/2003 | WO2003072081A1 Ophthalmic formulation with gum system |
| 09/04/2003 | WO2003072080A1 Inhalable formulations for sustained release |
| 09/04/2003 | WO2003072071A1 Topical dapsone for the treatment of acne |
| 09/04/2003 | WO2003072060A2 Polypeptide formulation |
| 09/04/2003 | WO2003072056A2 Intranasal administration of mc4-r agonists |
| 09/04/2003 | WO2003072025A2 Modified release formulations of at least one form of tramadol |
| 09/04/2003 | WO2003072022A2 Oral trimethobenzamide formulations and methods |
| 09/04/2003 | WO2003072021A2 Oral pediatric trimethobenzamide formulations and methods |
| 09/04/2003 | WO2003072020A2 Therapeutical polyanhydride compounds for drug delivery |
| 09/04/2003 | WO2003072016A2 Pharmaceutical compositions in particulate form |